300,000 Antibody Cocktail Doses Purchased by the USA
October 12, 2020 • 5:17 am CDT
The CEO of Regeneron Dr. Leonard Schleifer told CBS News on October 11, 2020, the company's $450 million contract with the U.S. government will secure roughly 300,000 doses of the experimental REGN-COV2 Antibody Cocktail treatment for COVID-19 patients.